Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study.
Tomohiro KogaMasataka UmedaYushiro EndoMidori IshidaYuya FujitaSosuke TsujiAyuko TakataniToshimasa ShimizuRemi SumiyoshiTakashi IgawaShoichi FukuiAyako NishinoShin-Ya KawashiriNaoki IwamotoKunihiro IchinoseMami TamaiHideki NakamuraTomoki OriguchiNaoko MurakamiMichio KitajimaAtsushi KawakamiPublished in: International journal of rheumatic diseases (2018)
The combined use of GnRH-a with IVCY therapy was associated with a significant reduction of POF among premenopausal women with SLE, suggesting that the addition of GnRH-a can be a strategy to prevent POF among premenopausal women with SLE after IVCY therapy.